Marcelle Tuttle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marcelle Tuttle has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Chavez
Wyss Institute at Harvard University
1 shared publication - Benjamin W. Pruitt
Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, Massachusetts, USA
1 shared publication - Brian M Turczyk
Wyss Institute at Harvard University
1 shared publication - George McDonald Church
Department of Genetics, Harvard Medical School, Boston, MA, USA
1 shared publication - James J. Collins
Department of Biological Engineering and Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, USA
1 shared publication - Jordan Winston
Department of Plant Pathology, Physiology, and Weed Science, Virginia Tech University, Blacksburg, VA 24061, USA
1 shared publication
Latest Publications
- Open Access
Precise Cas9 targeting enables genomic mutation prevention
Here we present a generalized method of guide RNA “tuning” that enables Cas9 to discriminate between two target sites that differ by a single nucleotide polymorphism. We employ our methodology to generate a novel in vivo mutation prevention system in which Cas9 actively restricts the occurrence of undesired gain-of-function mutations within a population of engineered organisms. We further demonstrate that the system is scalable to a multitude of targets and that the general tuning and prevention concepts are portable across engineered Cas9 variants and Cas9 orthologs. Finally, we show that the designed mutation prevention system maintains robust activity even when placed within the complex environment of the mouse gastrointestinal tract.
Open AccessPrecise Cas9 targeting enables genomic mutation prevention
Here we present a generalized method of guide RNA “tuning” that enables Cas9 to discriminate between two target sites that differ by a single nucleotide polymorphism. We employ our methodology to generate a novel in vivo mutation prevention system in which Cas9 actively restricts the occurrence of undesired gain-of-function mutations within a population of engineered organisms. We further demonstrate that the system is scalable to a multitude of targets and that the general tuning and prevention concepts are portable across engineered Cas9 variants and Cas9 orthologs. Finally, we show that the designed mutation prevention system maintains robust activity even when placed within the complex environment of the mouse gastrointestinal tract.